PRKAA1 and neoplasm: Since this model used T cell-specific knockouts, where expression of PTEN and AMPK would have been normal in all other cells, this proved that pharmacological activation of AMPK could protect against tumour development via a cell-autonomous effect occurring within the tumour progenitor cells themselves [85].